---
$id: https://graph.org.ai/products/commodity/51282921
$type: Product
source: UNSPSC
code: "51282921"
title: "Gatifloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gatifloxacin

**UNSPSC Code**: 51282921
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula 2C19H22FN3O4.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, L4618BD7KJ chemically known as (+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, sesquihydrate but generally known as gatifloxacin, which bears US NIH Compound Identifier 5379. European Medicines Agency schedules Gatifloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13952MIG. The term GATIFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, no. 3, 1996, list 36. ). Most nations schedule gatifloxacin under HS 29335995 and SITC 51576. As of Q4 2014, GATIFLOXACIN remains the US FDA Preferred Term for this commodity. Gatifloxacin bears US NLM identifiers UMLS ID C1258065 and NCI Concept Code C29070. SMILES: FC1C(N2CC(NCC2)C)C(OC)C2N(C3CC3)CC(C(=O)C2C1)C(=O)O.

